Shaping the bone through iron and iron-related proteins.
Hemochromatosis proteins
Iron
Osteoblast
Osteoclast
Osteoporosis
Journal
Seminars in hematology
ISSN: 1532-8686
Titre abrégé: Semin Hematol
Pays: United States
ID NLM: 0404514
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
26
02
2021
revised:
18
05
2021
accepted:
08
06
2021
entrez:
14
8
2021
pubmed:
15
8
2021
medline:
6
4
2022
Statut:
ppublish
Résumé
Well-controlled iron levels are indispensable for health. Iron deficiency is the most common cause of anemia, whereas iron overload, either hereditary or secondary due to disorders of ineffective erythropoiesis, causes widespread organ failure. Bone is particularly sensitive to fluctuations in systemic iron levels as both iron deficiency and overload are associated with low bone mineral density and fragility. Recent studies have shown that not only iron itself, but also iron-regulatory proteins that are mutated in hereditary hemochromatosis can control bone mass. This review will summarize the current knowledge on the effects of iron on bone homeostasis and bone cell activities, and on the role of proteins that regulate iron homeostasis, i.e. hemochromatosis proteins and proteins of the bone morphogenetic protein pathway, on bone remodeling. As disorders of iron homeostasis are closely linked to bone fragility, deeper insights into common regulatory mechanisms may provide new opportunities to concurrently treat disorders affecting iron homeostasis and bone.
Identifiants
pubmed: 34389111
pii: S0037-1963(21)00034-2
doi: 10.1053/j.seminhematol.2021.06.002
pii:
doi:
Substances chimiques
Iron
E1UOL152H7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
188-200Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.